2003
DOI: 10.1046/j.1523-1755.64.s86.12.x
|View full text |Cite
|
Sign up to set email alerts
|

Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

12
116
0
11

Year Published

2004
2004
2013
2013

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 168 publications
(139 citation statements)
references
References 46 publications
12
116
0
11
Order By: Relevance
“…Only a very low level of expression of AT 2 R is detected in the adult kidney (Shanmugam et al 1995, Ozone et al 1997. AT 2 R is re-expressed, however, in proximal tubules after ischaemia (Kontogiannis & Burns 1998) and in human diabetic nephropathy (Mezzano et al 2003). We have previously reported the expression of AT 2 R in IRPTCs (Tang et al 1995).…”
Section: Discussionmentioning
confidence: 96%
“…Only a very low level of expression of AT 2 R is detected in the adult kidney (Shanmugam et al 1995, Ozone et al 1997. AT 2 R is re-expressed, however, in proximal tubules after ischaemia (Kontogiannis & Burns 1998) and in human diabetic nephropathy (Mezzano et al 2003). We have previously reported the expression of AT 2 R in IRPTCs (Tang et al 1995).…”
Section: Discussionmentioning
confidence: 96%
“…We studied patients under clamped euglycaemic conditions and using a controlled dietary preparation to isolate the effect of filtration status without the influence of acute hyperglycaemia, renal dysfunction or albuminuria [6]. Under these conditions, urinary factors that are associated with either chemotaxis or inflammation/fibrosis were elevated in DM-H [40][41][42]. Our results suggest that high intraglomerular pressure may provide a mechanistic link between factors that cause hyperfiltration, such as hyperglycaemia-induced renin angiotensin system activation [43], and renal inflammation, leading to the onset of clinical disease.…”
Section: Discussionmentioning
confidence: 99%
“…Angiotensin II modulates the immune response via the production of NF-κB in the cytoplasm of mature phagocytes, resulting in the transcription of inflammatory cytokines and chemokines, including IL-1beta, IL-6, IFN-gamma and TNF-alpha, and IL-8, MCP-1 and CAM-1, respectively. [8][9][10] Angiotensin-converting enzyme inhibitors reduce the expression of monocyte chemo-attractant protein-1 and concomitant macrophage plaque infiltration in animal models of atherosclerosis. 11 In patients with carotid artery disease, the angiotensin receptor blocker irbersartan inhibits metalloproteinase activity, as well as T-cell and macrophage infiltration in the vascular wall.…”
Section: Introductionmentioning
confidence: 99%